InvestorsHub Logo
Followers 4
Posts 1242
Boards Moderated 0
Alias Born 01/16/2016

Re: Duke2484 post# 1258

Monday, 02/08/2016 5:55:39 PM

Monday, February 08, 2016 5:55:39 PM

Post# of 6602
Duke, the latest update is this:

After the latest (non disclosed) December 3rd meeting with the FDA things are looking positive according to CEO, Nathan Harding.

Nathan said something like 'we see the light at the end of the tunnel and it is a good light'.

Here's the critical timeline:

Ekso Bionics is required to send more information by March 7th and the FDA has 30 days to respond. The FDA does have the option to delay if they choose. Ekso Bionics is seeking a special label at the FDA that includes both spinal cord injury and stroke. (Nathan said that this FDA label will be a unique industry first if approved).

I personally believe it's very important Ekso did not disclose the latest meeting with the FDA formally. Trying to keep it a secret from competitors is smart and it may mean that the approval is coming soon.

This is all from their development day event sourced here:

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EKSO News